VANCOUVER, BC — GLOBE NEWSWIRE — Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function,… Read More
LSBC President and CEO, Wendy Hurlburt, took part in Resilient Healthcare Coalition’s online panel, How a Robust Canadian Life Sciences Strategy Will Drive Health and Wealth. Chaired by Dr. Jason… Read More
OTTAWA, ON— BioTalent Canada is proud to announce that it has been named to the 2021 list of Best Workplaces for Mental Wellness. In addition, the organization has also been… Read More
Victoria, B.C. – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced that it has entered… Read More
Just in time for its annual online sale event, Amazon has gotten the green light from the FDA to begin hawking its own COVID-19 test directly to consumers—potentially setting up… Read More
